These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11992690)

  • 1. Topical immunization using nanoengineered genetic vaccines.
    Cui Z; Mumper RJ
    J Control Release; 2002 May; 81(1-2):173-84. PubMed ID: 11992690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic immunization using nanoparticles engineered from microemulsion precursors.
    Cui Z; Mumper RJ
    Pharm Res; 2002 Jul; 19(7):939-46. PubMed ID: 12180545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of co-administration of adjuvants with a nanoparticle-based genetic vaccine delivery system on the resulting immune responses.
    Cui Z; Mumper RJ
    Eur J Pharm Biopharm; 2003 Jan; 55(1):11-8. PubMed ID: 12551699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device.
    Cui Z; Baizer L; Mumper RJ
    J Biotechnol; 2003 Apr; 102(2):105-15. PubMed ID: 12697387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic immunization by jet injection of targeted pDNA-coated nanoparticles.
    Mumper RJ; Cui Z
    Methods; 2003 Nov; 31(3):255-62. PubMed ID: 14511958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmid DNA-entrapped nanoparticles engineered from microemulsion precursors: in vitro and in vivo evaluation.
    Cui Z; Mumper RJ
    Bioconjug Chem; 2002; 13(6):1319-27. PubMed ID: 12440869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal administration of plasmid DNA-coated nanoparticles results in enhanced immune responses.
    Cui Z; Mumper RJ
    J Pharm Pharmacol; 2002 Sep; 54(9):1195-203. PubMed ID: 12356273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-based nanoparticles for topical genetic immunization.
    Cui Z; Mumper RJ
    J Control Release; 2001 Aug; 75(3):409-19. PubMed ID: 11489327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical characterization and macrophage cell uptake of mannan-coated nanoparticles.
    Cui Z; Hsu CH; Mumper RJ
    Drug Dev Ind Pharm; 2003 Jul; 29(6):689-700. PubMed ID: 12889787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens.
    Hartikka J; Bozoukova V; Ferrari M; Sukhu L; Enas J; Sawdey M; Wloch MK; Tonsky K; Norman J; Manthorpe M; Wheeler CJ
    Vaccine; 2001 Feb; 19(15-16):1911-23. PubMed ID: 11228361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective humoral immune response from a H1N1 DNA vaccine delivered to the skin by microneedles coated with PLGA-based cationic nanoparticles.
    Seok H; Noh JY; Lee DY; Kim SJ; Song CS; Kim YC
    J Control Release; 2017 Nov; 265():66-74. PubMed ID: 28434892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome-mediated DNA vaccination: the effect of vesicle composition.
    Perrie Y; Frederik PM; Gregoriadis G
    Vaccine; 2001 Apr; 19(23-24):3301-10. PubMed ID: 11312029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic influenza virosomes as an adjuvanted delivery system for CTL induction by DNA vaccination.
    Jamali A; Holtrop M; de Haan A; Hashemi H; Shenagari M; Memarnejadian A; Roohvand F; Sabahi F; Kheiri MT; Huckriede A
    Immunol Lett; 2012; 148(1):77-82. PubMed ID: 22981929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel ethanol-in-fluorocarbon microemulsions for topical genetic immunization.
    Cui Z; Fountain W; Clark M; Jay M; Mumper RJ
    Pharm Res; 2003 Jan; 20(1):16-23. PubMed ID: 12608531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microparticles and nanoparticles as delivery systems for DNA vaccines.
    Cui Z; Mumper RJ
    Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):103-37. PubMed ID: 14584521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection site-dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination.
    Guan X; Nishikawa M; Takemoto S; Ohno Y; Yata T; Takakura Y
    J Gene Med; 2010 Mar; 12(3):301-9. PubMed ID: 20084616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines.
    Anwer K; Earle KA; Shi M; Wang J; Mumper RJ; Proctor B; Jansa K; Ledebur HC; Davis S; Eaglstein W; Rolland AP
    Pharm Res; 1999 Jun; 16(6):889-95. PubMed ID: 10397610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
    Khatri K; Goyal AK; Gupta PN; Mishra N; Vyas SP
    Int J Pharm; 2008 Apr; 354(1-2):235-41. PubMed ID: 18182259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses.
    Yoshida A; Nagata T; Uchijima M; Higashi T; Koide Y
    Vaccine; 2000 Mar; 18(17):1725-9. PubMed ID: 10699319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.